SCHEMBL27768199

SCHEMBL27768199

CCc1cc(C(=O)O)ccc1/C=C/C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ NR1I2 O75469 1/20 0.41
▸ PGR P06401 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41
▸ TBXAS1 P24557 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2130625 0.83 TDP1 (0.43) MEN1KMT2ACYP3A4LMNAHTT
SCHEMBL2130629 0.83 TDP1 (0.43) MEN1KMT2ACYP3A4LMNAHTT
SCHEMBL67953 0.83 PTGS2 (0.47) PTGS1PTGS2MEN1NPC1RAB9A
SCHEMBL6438554 0.81 RAB9A (0.54) PTGS1PTGS2MEN1NPC1RAB9A
SCHEMBL18069237 0.79 LMNA (0.53) MEN1KMT2ACYP3A4LMNAHTT
SCHEMBL30782971 0.79 LMNA (0.53) MEN1KMT2ACYP3A4LMNAHTT
SCHEMBL4579922 0.75 MAPT (0.54) KMT2ACYP3A4MAPTTDP1NR1H4
SCHEMBL4579930 0.75 MAPT (0.54) KMT2ACYP3A4MAPTTDP1NR1H4
SCHEMBL15630779 0.74 LMNA (0.41) NPC1RAB9ACYP3A4LMNAHTT
SCHEMBL4324689 0.73 ALDH1A1 (0.47) PTGS1PTGS2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101563347-A Vasopressin V1a antagonists VANTIA LTD (GB) 2009-10-21 — — CN disclosed
Send feedback